International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 895-899 doi: 10.5281/zenodo.16918183
Original Article
Unusual Left Atrial Thrombus in an Infant After Sustained Supraventricular Tachycardia
 ,
Published
Aug. 21, 2025
Abstract

Intracardiac thrombus in infants is an exceptionally rare finding and often associated with underlying congenital heart disease, central venous catheters, or coagulation abnormalities. Left atrial thrombi are typically encountered in adults with atrial fibrillation, but their occurrence in infants without structural heart defects is unusual. We report the case of an infant who developed a large left atrial thrombus following sustained supraventricular tachycardia (SVT). Echocardiography revealed dilated atria, atrioventricular valve regurgitation, and a large clot in the left atrial appendage. The child was managed conservatively with anticoagulation, resulting in significant thrombus resolution over 45 days. This case highlights the importance of early echocardiographic evaluation in infants with persistent arrhythmia and demonstrates the efficacy of anticoagulation therapy in resolving thrombi without surgical intervention.

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
1721 Views
446 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved